STOCK TITAN

Envista Holdings Corporation - $NVST STOCK NEWS

Welcome to our dedicated page for Envista Holdings Corporation news (Ticker: $NVST), a resource for investors and traders seeking the latest updates and insights on Envista Holdings Corporation stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Envista Holdings Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Envista Holdings Corporation's position in the market.

Rhea-AI Summary

Envista Holdings (NYSE: NVST) reported sales of $623.6 million for the first quarter of 2024, with a 0.4% increase in core sales compared to 2023. Net income was $23.6 million, adjusted net income $45.8 million, and adjusted EBITDA $87.2 million. The company appointed Paul Keel as the new CEO. Envista remains focused on growth and profitability with a strong outlook for the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
-
News
Rhea-AI Summary
Envista Holdings (NVST) announced the appointment of Paul Keel as CEO and Board member, effective May 1, 2024. Keel brings a strong track record in global innovation and medical markets, aiming to digitize dental care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.34%
Tags
none
-
Rhea-AI Summary
Envista Holdings (NVST) announced that the Envista Smile Project donated $1.2 million in 2023 to improve access to oral health. The donations more than doubled from 2022, reaching over $2.2 million in total value of goods and services since 2021. The Smile Project provided dental care, goods, and funds to various organizations globally, impacting over 19,000 patients in need.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.53%
Tags
none
Rhea-AI Summary
Envista Holdings (NVST) will release its first-quarter 2024 financial results on May 1, 2024. The conference call to discuss these results will be held at 2:00 PM PT. The webcast will be available on Envista's website, with a replay option. Investors can access the call via phone or webcast.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
-
Rhea-AI Summary
DEXIS introduces IS ScanFlow v.1.0.10, enhancing dental implant workflows with guided workflows and AI capabilities. The update aims to boost productivity for clinicians by simplifying data capture in complex situations, automating manual tasks, and facilitating efficient lab communication. Early adopters have provided positive feedback on the system's ease of use and accuracy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.49%
Tags
none
-
Rhea-AI Summary
Envista Holdings Corporation (NVST) has initiated the process to select a new CEO to succeed Amir Aghdaei, who will continue as President until the appointment. The board is actively searching for external candidates to drive the company's future growth and transformation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.19%
Tags
none
Rhea-AI Summary
DEXIS introduces an AI-powered digital ecosystem for implant dentistry workflows, offering integrated tools for diagnosis, treatment planning, and collaboration. The platform includes advanced imaging technology, AI-driven software, and user-friendly features to enhance clinical efficiency and patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.92%
Tags
AI
-
Rhea-AI Summary
Envista Holdings Corporation (NVST) reported a decline in core sales by 2.0% in Q4 2023, with a net loss of $217.4 million. Adjusted net income was $49.7 million, down from $91.9 million in Q4 2022. The company is focusing on improving Spark profitability and accelerating its North American implant business in 2024, expecting low-single digit core sales growth and adjusted EBITDA margins of 16% - 17%. The company delivered $223.6 million of free cash flow for the full year 2023, representing an increase of more than $100 million over 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.43%
Tags
-
Rhea-AI Summary
Envista Holdings Corporation (NVST) has joined Women in DSO as a Platinum Industry partner, demonstrating its commitment to advancing female leadership in dentistry. The partnership aims to support women in realizing their career aspirations and developing the next generation of female leaders in the dental space.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.02%
Tags
partnership
Rhea-AI Summary
Envista Holdings Corporation (NVST) announced an Investor Event at the Envista Summit on February 16, 2024. The event will feature a management presentation and interactive Q&A. The Summit aims to provide dental professionals with training and education on the company's product portfolio and digitally integrated solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.08%
Tags
conferences
Envista Holdings Corporation

NYSE:NVST

NVST Rankings

NVST Stock Data

3.27B
170.96M
0.42%
109.55%
6.31%
Dental Equipment and Supplies Manufacturing
Manufacturing
Link
United States of America
BREA

About NVST

we know that dental professionals do more than create healthy, beautiful smiles—they create confidence. to achieve their goals, they need a champion. they need someone who will be there for them, side by side and end to end. at envista, we are uniquely positioned to be this champion. our differentiated combination of continuous improvement, a bias toward action and innovation, and a deep respect for the professionals we serve embolden us to champion dental professionals like no one else can. our comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. we believe true champions lift each other up, and we are looking for new champions to join our team. if you believe, champions do more than win, they stand for something bigger, you can build a meaningful career at envista. if you believe champions work to be their best, help others be theirs, sho